Not provided
Not provided
Not provided
Not provided
Not provided
grunnet COVID-19 pandemien då vi haft hög drop-out og vanskelig att rekruttere
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate if playing a newly developed videogame that requires physical activity (e.g. exergame), leads to increased physical activity and health benefits in children and adolescents who do not regularly participate in endurance training. Health benefits will be expressed in physical fitness (maximal oxygen consumption), blood markers of a healthy heart, body composition and objectively measured physical activity. Gaming frequency of the participants will be registered throughout the 24 week intervention period.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exergaming | Experimental | 24 week access to the exergaming platform PlayPulse |
|
| Control | No Intervention | Asked to continue with their normal daily routine |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exergaming | Behavioral | free access to the exergaming platform PlayPulse for 24 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| VO2max | Maximal Aerobic Capacity | 12 weeks |
| VO2max | Maximal Aerobic Capacity | 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change in daily average energy expenditure | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. | Baseline, 12 and 24 weeks |
| Change in daily time in sedentary activity (<3.0 metabolic equivalents =METs) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Øystein Risa, PhD | Norwegian University of Science and Technology | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Circulation and Medical Imaging | Trondheim | 7491 | Norway |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 42103774 | Derived | Berg J, Wang AI, Madssen E, Roe L, Moholdt T. Effects of providing access to a cycling exergaming platform on cardiorespiratory fitness and cardiometabolic health in adolescents: a randomised, controlled trial. Sci Rep. 2026 May 8;16(1):21098. doi: 10.1038/s41598-026-48327-3. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D057185 | Sedentary Behavior |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D000088544 | Exergaming |
| ID | Term |
|---|---|
| D015444 | Exercise |
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. |
| Baseline, 12 and 24 weeks |
| Change in daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs) | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. | Baseline, 12 and 24 weeks |
| Change in daily time in vigorous intensity activity (6.0-9.0 metabolic equivalents = METs) | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. | Baseline, 12 and 24 weeks |
| Change in daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs) | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. | Baseline, 12 and 24 weeks |
| Change in daily average total physical activity duration | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. | Baseline, 12 and 24 weeks |
| Change in daily average number of steps | Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks. | Baseline, 12 and 24 weeks |
| Bioelectrical impedance | Body composition assessed using bioelectrical impedance analysis (InBody 720) | 12 and 24 weeks |
| systolic Blood Pressure | 12 and 24 weeks |
| Diastolic Blood Pressure | 12 and 24 weeks |
| Fasting circulating glucose, as blood marker of cardiometabolic health | 24 weeks |
| Lipid profile, as blood marker of cardiometabolic health | 24 weeks |
| Circulating insulin concentration, as blood marker of cardiometabolic health | 24 weeks |
| HbA1c from blood samples | 24 weeks |
| D055687 |
| Musculoskeletal and Neural Physiological Phenomena |